APP/PS1 mice at this age have yet to present stereotypical amyloid or tau pathology within the brain and therefore provide an opportunity to assess whether device injury triggers the aggregation of amyloid or tau protein prior to the temporally defined onset of neuropathology within the AD model. The gene discussed is MAPT; the disease is Alzheimer disease.